Tag: medicinal cannabis sector
Cann Group receives $3.2M R&D refund for cannabis med manufacture
Medicinal cannabis supplier and manufacturer Cann Group Limited (ASX:CAN) received today a research and development (R&D) tax incentive refund amounting to $3.2 million.
The Australian...
Cann Group inks broad R&D agreement with CSIRO
Listed medicinal cannabis company Cann Group has inked a broad, multiyear agreement with CSIRO that extends the research and development collaboration between the two parties.
The...
Featured Article
Sydney to spotlight the latest in manufacturing at AMW 2024
With the Australian Manufacturing Week (AMW) 2024 fast approaching, Sydney is set to become the epicentre of groundbreaking innovations in the advanced manufacturing sector.Â
